SOURCE: BIO-key International, Inc.

BIO-key International, Inc.

September 07, 2012 08:00 ET

BIO-key® International, Inc. Presenting Fingerprint Biometric Authentication Technology for EHR & ePrescriptions at Epic Annual User Group Meeting

WALL, NJ--(Marketwire - Sep 7, 2012) - BIO-key International, Inc. (OTCBB: BKYI), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported that the company will be presenting the latest advances in fingerprint biometric authentication technology for hospitals and healthcare providers at Epic's Annual User Group Meeting in Verona, Wisconsin, September 11th - 13th.

BIO-key will be demonstrating how our award-winning technology is enabling hospital staff members to increase the time they spend caring for patients by streamlining the process for accessing and updating patient records. BIO-key technology is uniquely positioned to offer optimum convenience for providers, while raising the level of security for the organization. Many hospitals are turning to BIO-key to meet the DEA and various State Boards of Pharmacy Two-Factor compliance requirements.

Research that BIO-key has conducted with prospective customers, along with discussions with their existing customer base, has shown that providers consistently stated they were very frustrated with current authentication process; which requires them to submit passwords dozens, if not hundreds, of times per day to access records and update notes.

At this year's Epic UGM, BIO-key will be presenting a new interactive ROI worksheet which measures the amount of time hospitals save when they streamline the log-in process by incorporating BIO-key technology.

"It's an honor to attend the 'invitation only' Epic User Group Meeting," said Scott Mahnken, Vice President of Marketing at BIO-key. "Epic is the recognized world leader in EHR/EMR technology and many of the largest, most highly regarded hospitals are Epic customers. BIO-key provides Epic customers with highly accurate finger biometric technology which allows them to minimize the use of less secure, often compromised passwords in favor of our faster, more convenient multi-factor compliant solution. We know that there's a better way; as witnessed by the increase of hospitals electing to integrate our technology. In fact, every single healthcare organization that has tested our software has moved forward with integration; a testament not only to our performance but to the preferences of the providers," added Mahnken.

About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)

BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

Contact Information

  • Contacts:
    BIO-key International, Inc.
    Scott Mahnken
    732-359-1113